Back to mobile site

BofA/Merrill Lynch Starts Achillion Pharmaceuticals (ACHN) at Buy

February 4, 2011 7:32 AM EST Send to a Friend
BofA/Merrill Lynch initiates coverage on Achillion Pharmaceuticals (NASDAQ: ACHN) with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login